Ian R. Reid

51.9k total citations · 13 hit papers
492 papers, 31.4k citations indexed

About

Ian R. Reid is a scholar working on Orthopedics and Sports Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ian R. Reid has authored 492 papers receiving a total of 31.4k indexed citations (citations by other indexed papers that have themselves been cited), including 299 papers in Orthopedics and Sports Medicine, 177 papers in Oncology and 120 papers in Pathology and Forensic Medicine. Recurrent topics in Ian R. Reid's work include Bone health and osteoporosis research (261 papers), Bone health and treatments (165 papers) and Vitamin D Research Studies (114 papers). Ian R. Reid is often cited by papers focused on Bone health and osteoporosis research (261 papers), Bone health and treatments (165 papers) and Vitamin D Research Studies (114 papers). Ian R. Reid collaborates with scholars based in New Zealand, United States and United Kingdom. Ian R. Reid's co-authors include Andrew Grey, Mark J Bolland, Greg Gamble, Anne Horne, Ruth Ames, Jillian Cornish, M C Evans, Karen E. Callon, Richard Eastell and Steven R. Cummings and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Ian R. Reid

479 papers receiving 30.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

2009 2.4k citations Steven R. Cummings, Javier San Martín et al. New England Journal of Medicine profile →
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

2010 710 citations Mark J Bolland, A Avenell et al. BMJ profile →
Postmenopausal osteoporosis

2016 594 citations Richard Eastell, Ian R. Reid et al. profile →
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis

2011 578 citations Mark J Bolland, Andrew Grey et al. BMJ profile →
Relationships among body mass, its components, and bone11Published simultaneously at BoneKEy-Osteovision (http://www.bonekey-ibms.org), a Web site sponsored by the International Bone and Mineral Society.

2002 516 citations Ian R. Reid profile →
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

2011 477 citations Dennis M. Black, Ian R. Reid et al. Journal of Bone and Mineral Research profile →
Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis

2013 473 citations Ian R. Reid, Mark J Bolland et al. profile →
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

2008 453 citations Mark J Bolland, Anne Horne et al. BMJ profile →
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis

2014 297 citations Mark J Bolland, Andrew Grey et al. profile →
Calcium intake and bone mineral density: systematic review and meta-analysis

2015 274 citations Andrew Grey, Ian R. Reid et al. profile →
Fracture Prevention with Zoledronate in Older Women with Osteopenia

2018 259 citations Ian R. Reid, Anne Horne et al. New England Journal of Medicine profile →
A broader strategy for osteoporosis interventions

2020 196 citations Ian R. Reid profile →
Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age

2025 15 citations Mark J Bolland, Andrew Grey et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian R. Reid New Zealand	98	17.2k	11.0k	8.4k	6.8k	4.2k	492	31.4k
René Rizzoli Switzerland	90	15.9k 0.9×	7.5k 0.7×	6.6k 0.8×	4.6k 0.7×	6.6k 1.6×	476	30.4k
Richard Eastell United Kingdom	109	26.7k 1.5×	17.5k 1.6×	11.8k 1.4×	6.0k 0.9×	9.8k 2.3×	632	42.6k
John A. Eisman Australia	95	18.3k 1.1×	6.4k 0.6×	6.8k 0.8×	7.7k 1.1×	8.6k 2.0×	332	30.1k
Clifford J. Rosen United States	101	16.5k 1.0×	9.6k 0.9×	16.0k 1.9×	7.6k 1.1×	4.4k 1.1×	575	43.6k
Maria Luisa Brandi Italy	83	8.8k 0.5×	8.8k 0.8×	7.9k 0.9×	3.7k 0.5×	6.4k 1.5×	770	29.6k
Huibert A. P. Pols Netherlands	90	11.9k 0.7×	5.0k 0.4×	6.9k 0.8×	5.0k 0.7×	7.0k 1.7×	238	31.6k
Peter R. Ebeling Australia	80	6.8k 0.4×	5.0k 0.5×	4.2k 0.5×	5.6k 0.8×	4.4k 1.0×	568	23.6k
Leif Mosekilde Denmark	84	9.1k 0.5×	5.4k 0.5×	4.7k 0.6×	5.5k 0.8×	4.8k 1.2×	383	22.9k
L. Joseph Melton United States	84	21.4k 1.2×	8.2k 0.7×	8.2k 1.0×	5.3k 0.8×	11.7k 2.8×	170	37.7k
John P. Bilezikian United States	112	17.0k 1.0×	15.4k 1.4×	10.7k 1.3×	7.1k 1.0×	10.7k 2.6×	623	43.4k

Countries citing papers authored by Ian R. Reid

Since Specialization

Citations

This map shows the geographic impact of Ian R. Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian R. Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian R. Reid more than expected).

Fields of papers citing papers by Ian R. Reid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian R. Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian R. Reid. The network helps show where Ian R. Reid may publish in the future.

Co-authorship network of co-authors of Ian R. Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Ian R. Reid. A scholar is included among the top collaborators of Ian R. Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian R. Reid. Ian R. Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reid, Ian R.. (2025). Calcium Supplementation- Efficacy and Safety. Current Osteoporosis Reports. 23(1). 8–8. 2 indexed citations

Black, Dennis M., Ian R. Reid, Nicola Napoli, et al.. (2020). The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial. Journal of Bone and Mineral Research. 37(1). 21–28. 14 indexed citations

Billington, Emma O. & Ian R. Reid. (2020). Benefits of Bisphosphonate Therapy: Beyond the Skeleton. Current Osteoporosis Reports. 18(5). 587–596. 28 indexed citations

Billington, Emma O., Rinki Murphy, Greg Gamble, et al.. (2019). Fibroblast growth factor 23 levels decline following sleeve gastrectomy. Clinical Endocrinology. 91(1). 87–93. 9 indexed citations

Billington, Emma O., Greg Gamble, & Ian R. Reid. (2015). Reasons for discrepancies in hip fracture risk estimates using FRAX and Garvan calculators. Maturitas. 85. 11–18. 12 indexed citations

Patel, Dipika V., Mark J Bolland, Mukesh Singh, et al.. (2014). Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial. Osteoporosis International. 26(2). 499–503. 33 indexed citations

Reid, Ian R., Dennis M. Black, Richard Eastell, et al.. (2013). Reduction in the Risk of Clinical Fractures After a Single Dose of Zoledronic Acid 5 Milligrams. The Journal of Clinical Endocrinology & Metabolism. 98(2). 557–563. 76 indexed citations

Grey, Andrew, Mark J Bolland, & Ian R. Reid. (2012). Vitamin D dose requirements for fracture prevention.. New England Journal of Medicine. 367(14). 1367. 4 indexed citations

Black, Dennis M., Ian R. Reid, Steven Boonen, et al.. (2011). The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). Journal of Bone and Mineral Research. 27(2). 243–254. 477 indexed citations breakdown →

10.

Bolland, Mark J, A Avenell, John A. Baron, et al.. (2010). Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 341(jul29 1). c3691–c3691. 710 indexed citations breakdown →

11.

Reid, Ian R., Mark J Bolland, & Andrew Grey. (2010). Does calcium supplementation increase cardiovascular risk?. Clinical Endocrinology. 73(6). 689–695. 54 indexed citations

12.

Williams, Garry A, Yu Wang, Karen E. Callon, et al.. (2009). In Vitro and in Vivo Effects of Adiponectin on Bone. Endocrinology. 150(8). 3603–3610. 181 indexed citations

13.

Cummings, Steven R., Javier San Martín, Michael R. McClung, et al.. (2009). Denosumab for Prevention of Fractures in Postmenopausal Women With Osteoporosis. Obstetrical & Gynecological Survey. 64(12). 805–807. 41 indexed citations

14.

Recker, Robert R., Pierre D. Delmas, Johan Halse, et al.. (2007). Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure. Journal of Bone and Mineral Research. 23(1). 6–16. 170 indexed citations

15.

Eastell, Richard, Dennis M. Black, Jane A. Cauley, et al.. (2007). Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis. 14. 2 indexed citations

16.

Cornish, Jillian, Karen E. Callon, Dorit Naot, et al.. (2004). Lactoferrin Is a Potent Regulator of Bone Cell Activity and Increases Bone Formation in Vivo. Endocrinology. 145(9). 4366–4374. 232 indexed citations

17.

Reid, Ian R.. (2001). Time to End Steroid-Induced Fractures. Archives of Dermatology. 137(4). 493–493. 2 indexed citations

18.

Grey, Andrew, et al.. (1996). Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post‐menopausal women. Clinical Endocrinology. 44(3). 293–296. 35 indexed citations

19.

Reid, Ian R.. (1989). Steroid osteoporosis. Calcified Tissue International. 45(2). 63–67. 33 indexed citations

20.

Reid, Ian R., H.K. Ibbertson, John T. France, & J Pybus. (1985). Plasma testosterone concentrations in asthmatic men treated with glucocorticoids.. BMJ. 291(6495). 574.1–574. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact